ST. LOUIS — A study published by Washington University scientists sheds new light on the potential long-term strategy for vaccinating against the virus that causes COVID-19.
The study, published Monday in Nature, adds to the wealth of research on how the COVID-19 vaccines induce an immune defense. The researchers found that a COVID-19 vaccine that specifically targeted the omicron variant of the virus generated cells that fight the variant, as well as earlier strains.
"I think our paper makes a case that updating the vaccine is important," said Ali Ellebedy, an associate professor at Washington University and senior author of the study.
